SERALENE non-absorbable blue (4/0) HR-17 needle 75 cm box of 24 sutures - Serag-Wiessner (LO15341C) - Delynov

What is the non-absorbable SERALENE 4/0 suture?

SERALENE is a 4/0 non-absorbable surgical suture in blue color, developed by the manufacturer Serag-Wiessner. This device is presented as a monofilament thread offering a smooth surface for atraumatic passage through tissues. Its non-absorbable structure guarantees constant tension stability over time, which is crucial for interventions requiring prolonged healing support. This product is packaged in boxes of 24 sutures, each thread measuring 75cm, thus optimizing its use during various clinical procedures in dental offices or hospital environments.

What are the clinical indications for this 4/0 non-absorbable suture?

This 4/0 non-absorbable suture is particularly indicated in oral, periodontal, and implant surgery. Its USP 4/0 gauge is ideal for closing flaps of medium density and for suturing techniques requiring tensile strength without compromising the vascularization of the edges. It is perfectly suited for graft stabilization, extraction site closures, or implant loading procedures. The non-absorbable nature of the material allows the practitioner to precisely control the duration the suture remains in place until its manual removal during the follow-up visit.

What are the technical characteristics of the HR-17 needle?

The HR-17 needle associated with this SERALENE suture has specific properties for fine surgery. The 'HR' code designates a 1/2 circle round-bodied needle, a configuration specifically designed for deep sutures and ligatures. The round point allows for passing through tissues without cutting them, thus minimizing the risk of accidental tissue tearing. The number '17' indicates a body length of 17 mm, offering an optimal compromise between maneuverability in the restricted spaces of the oral cavity and robustness when passing through denser tissues.

What are the contraindications for the use of SERALENE?

As with any suturing device, the use of non-absorbable SERALENE is contraindicated in patients with a known hypersensitivity to the components of the material. Although the exact specifications of the polymer are not detailed here, it is imperative to validate the absence of allergy to blue synthetic sutures. Furthermore, its non-absorbable nature makes it unsuitable for situations where spontaneous absorption is necessary, such as in certain internal tissue layers inaccessible for subsequent removal. The practitioner must systematically refer to the instructions for use provided by Serag-Wiessner GmbH & Co. KG.

What are the precautions related to the non-absorbable nature and handling?

Since SERALENE is a non-absorbable suture, it requires removal by the practitioner once clinical healing is achieved. During placement, it is recommended to perform secure knots, as the monofilament structure may exhibit shape memory. Particular attention must be paid to the tension applied to avoid any tissue ischemia. The 75cm length of the thread provides sufficient room for maneuver to secure knots without excessive tension. It is advised to follow standard post-operative care protocols to monitor the integrity of the suture until its removal.

Who is the manufacturer and what are the quality guarantees?

The product is manufactured by Serag-Wiessner GmbH & Co. KG, a manufacturer recognized for its expertise in the design of high-precision suturing devices. The Serag-Wiessner brand is synonymous with industrial rigor in the medical field. Although the specific regulatory class and CE marking are not mentioned in the source data, this device is distributed by Delynov to meet the requirements of dental surgery professionals. Each box of 24 units (reference LO15341C) is subject to the manufacturer's rigorous quality controls to ensure the sterility and technical performance of the needle-thread assembly.

State of the art

Modern synthetic sutures - absorbable or non-absorbable - are central to wound healing in oral surgery. Recent advances focus on reducing post-operative infections.